IPCA Labs hits 43-month high on robust Q3FY19 results; gains 13% in a week

The stock rallied 7% to Rs 828, its highest level since August 28, 2015, gaining 13% in the past one week, against 2.3% decline in the S&P BSE Sensex.

Shares of Ipca Laboratories hit a 43-month high of Rs 828 apiece, up 7 per cent on the BSE in intra-day trade on Monday, gaining 13 per cent in the past one week, on the back of healthy operational performance in December 2018 quarter (Q3FY19). In comparison, the S&P BSE Sensex was down 0.71 per cent today. The stock of pharmaceutical company was quoting at its highest level since August 28, 2015 and is 9.5 per cent away from its all-time high level of Rs 907 touched on February 28, 2014.

IPCA Lab’s Ebitda (earnings before interest, taxation, depreciation and